Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19

Detalhes bibliográficos
Autor(a) principal: Café, Júlia Figueiredo
Data de Publicação: 2022
Outros Autores: Moura , Nattan Rangel Fernandes, Pierote, Glenda Farias, Silva, Natiele Ramos, Bacelar, Juliana Abreu, Lacerda, Maria Clara Costa, Silva, Tatielle Pereira, Amorim, Aline Teixeira, Portela, Fernanda Santos
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/38199
Resumo: SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus) is the etiological agent responsible for the development of coronavirus disease (COVID-19). Which is a disease that affects the airways, and most often can cause pneumonia. Despite the viral origin, antimicrobial drugs are often prescribed, so that about 15% of patients with SARS-CoV-2 have a secondary infection caused by bacteria, which explains the antibiotic treatment. These drugs, when prescribed regardless of the existence of a bacterial infection, can lead to possible bacterial resistance. The objective of this work is to analyze the profile of laboratory tests of patients admitted to an ICU with severe forms of COVID-19, in a private hospital in a city in the southwestern region of Bahia. This is a documental study, with primary data source. The approach is quantitative, descriptive, exploratory, and cross-sectional, through data survey. Among the 52 medical records evaluated, it was possible to observe that the male gender had a higher rate of hospitalization and most of them were elderly. It is possible to observe an increase in the number of leukocytes and platelets after antibiotic therapy. And in relation to CRP, the value was significantly reduced after the administration of antimicrobial drugs. According to the analysis of the laboratory results, it was possible to observe that there were important alterations in the infection markers, which may be related to the use of antimicrobial drugs.
id UNIFEI_f6424d3e9640550d86f012832fed5090
oai_identifier_str oai:ojs.pkp.sfu.ca:article/38199
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19Perfil de las pruebas de laboratorio de los pacientes ingresados en una Unidad de Cuidados Intensivos (UCI) con formas graves de COVID-19Perfil dos exames laboratoriais dos pacientes internados em uma Unidade de Terapia Intensiva (UTI) com formas graves da COVID-19 UCICOVID-19ComorbilidadesDiagnóstico de laboratorio.ICUCOVID-19ComorbiditiesLab diagnosis.UTICOVID-19ComorbidadesDiagnostico laboratorial.SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus) is the etiological agent responsible for the development of coronavirus disease (COVID-19). Which is a disease that affects the airways, and most often can cause pneumonia. Despite the viral origin, antimicrobial drugs are often prescribed, so that about 15% of patients with SARS-CoV-2 have a secondary infection caused by bacteria, which explains the antibiotic treatment. These drugs, when prescribed regardless of the existence of a bacterial infection, can lead to possible bacterial resistance. The objective of this work is to analyze the profile of laboratory tests of patients admitted to an ICU with severe forms of COVID-19, in a private hospital in a city in the southwestern region of Bahia. This is a documental study, with primary data source. The approach is quantitative, descriptive, exploratory, and cross-sectional, through data survey. Among the 52 medical records evaluated, it was possible to observe that the male gender had a higher rate of hospitalization and most of them were elderly. It is possible to observe an increase in the number of leukocytes and platelets after antibiotic therapy. And in relation to CRP, the value was significantly reduced after the administration of antimicrobial drugs. According to the analysis of the laboratory results, it was possible to observe that there were important alterations in the infection markers, which may be related to the use of antimicrobial drugs.El SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus) es el agente etiológico responsable del desarrollo de la enfermedad por coronavirus (COVID-19). Que es una enfermedad que afecta a las vías respiratorias, y que en la mayoría de los casos puede causar neumonía. A pesar del origen vírico, a menudo se prescriben fármacos antimicrobianos, de modo que alrededor del 15% de los pacientes con SARS-CoV-2 tienen una infección secundaria causada por bacterias, lo que explica el tratamiento antibiótico. Estos fármacos, cuando se prescriben independientemente de la existencia de una infección bacteriana, pueden dar lugar a una posible resistencia bacteriana. El objetivo de este trabajo es analizar el perfil de las pruebas de laboratorio de los pacientes ingresados en una UCI con formas graves de COVID-19, en un hospital privado de una ciudad de la región suroeste de Bahía. Se trata de un estudio documental, con fuente de datos primarios. El abordaje es cuantitativo, descriptivo, exploratorio y transversal, a través de encuesta de datos. Entre las 52 historias clínicas evaluadas, fue posible observar que el género masculino tuvo un mayor índice de hospitalización y la mayoría de ellos eran ancianos. Es posible observar un aumento en el número de leucocitos y plaquetas después de la terapia antibiótica. Y en relación con la PCR, el valor se redujo significativamente después de la administración de antimicrobianos. De acuerdo con el análisis de los resultados de laboratorio, fue posible observar que hubo importantes alteraciones en los marcadores de infección, que pueden estar relacionados con el uso de medicamentos antimicrobianos.O SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus) é o agente etiológico responsável pelo desenvolvimento da doença do coronavírus (COVID-19). Que é uma doença que acomete as vias respiratórias, e na maior parte das vezes pode causar a pneumonia. Apesar da origem viral, frequentemente, são prescritos medicamentos antimicrobianos, sendo assim, cerca de 15% dos pacientes contagiados pelo SARS-CoV-2 apresentam um quadro de infecção secundária causada por bactérias, o que explica o tratamento com antibióticos. Esses fármacos, quando prescritos independentemente da existência de uma infecção causada por bactérias, podem acarretar em uma possível resistência bacteriana. O objetivo deste trabalho é analisar o perfil dos exames laboratoriais dos pacientes internados em uma UTI com formas graves da COVID-19, em um hospital privado de um município da região sudoeste da Bahia. Trata-se de um estudo de caráter documental, com fonte primária de dados. A abordagem é quantitativa de cunho descritivo, exploratório e de natureza transversal, por meio do levantamento de dados. Dentre os 52 prontuários avaliados, foi possível observar que o gênero masculino obteve uma maior taxa de internação e em sua maioria eram idosos. É possível observar um aumento do número de leucócitos e plaquetas, após a antibioticoterapia. E em relação a PCR, o valor foi significativamente reduzido, após a administração de fármacos antimicrobianos. De acordo com a análise dos resultados laboratoriais, foi possível observar que houve alterações importantes nos marcadores de infecção, o que pode estar relacionado com uso dos antimicrobianos.Research, Society and Development2022-12-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3819910.33448/rsd-v11i16.38199Research, Society and Development; Vol. 11 No. 16; e253111638199Research, Society and Development; Vol. 11 Núm. 16; e253111638199Research, Society and Development; v. 11 n. 16; e2531116381992525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/38199/31622Copyright (c) 2022 Júlia Figueiredo Café; Nattan Rangel Fernandes Moura ; Glenda Farias Pierote; Natiele Ramos Silva; Juliana Abreu Bacelar; Maria Clara Costa Lacerda; Tatielle Pereira Silva; Aline Teixeira Amorim; Fernanda Santos Portelahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCafé, Júlia Figueiredo Moura , Nattan Rangel Fernandes Pierote, Glenda Farias Silva, Natiele Ramos Bacelar, Juliana Abreu Lacerda, Maria Clara Costa Silva, Tatielle Pereira Amorim, Aline Teixeira Portela, Fernanda Santos 2022-12-18T18:26:42Zoai:ojs.pkp.sfu.ca:article/38199Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:52:02.347328Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
Perfil de las pruebas de laboratorio de los pacientes ingresados en una Unidad de Cuidados Intensivos (UCI) con formas graves de COVID-19
Perfil dos exames laboratoriais dos pacientes internados em uma Unidade de Terapia Intensiva (UTI) com formas graves da COVID-19
title Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
spellingShingle Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
Café, Júlia Figueiredo
UCI
COVID-19
Comorbilidades
Diagnóstico de laboratorio.
ICU
COVID-19
Comorbidities
Lab diagnosis.
UTI
COVID-19
Comorbidades
Diagnostico laboratorial.
title_short Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
title_full Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
title_fullStr Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
title_full_unstemmed Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
title_sort Profile of laboratory tests of patients admitted to an Intensive Care Unit (ICU) with severe forms of COVID-19
author Café, Júlia Figueiredo
author_facet Café, Júlia Figueiredo
Moura , Nattan Rangel Fernandes
Pierote, Glenda Farias
Silva, Natiele Ramos
Bacelar, Juliana Abreu
Lacerda, Maria Clara Costa
Silva, Tatielle Pereira
Amorim, Aline Teixeira
Portela, Fernanda Santos
author_role author
author2 Moura , Nattan Rangel Fernandes
Pierote, Glenda Farias
Silva, Natiele Ramos
Bacelar, Juliana Abreu
Lacerda, Maria Clara Costa
Silva, Tatielle Pereira
Amorim, Aline Teixeira
Portela, Fernanda Santos
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Café, Júlia Figueiredo
Moura , Nattan Rangel Fernandes
Pierote, Glenda Farias
Silva, Natiele Ramos
Bacelar, Juliana Abreu
Lacerda, Maria Clara Costa
Silva, Tatielle Pereira
Amorim, Aline Teixeira
Portela, Fernanda Santos
dc.subject.por.fl_str_mv UCI
COVID-19
Comorbilidades
Diagnóstico de laboratorio.
ICU
COVID-19
Comorbidities
Lab diagnosis.
UTI
COVID-19
Comorbidades
Diagnostico laboratorial.
topic UCI
COVID-19
Comorbilidades
Diagnóstico de laboratorio.
ICU
COVID-19
Comorbidities
Lab diagnosis.
UTI
COVID-19
Comorbidades
Diagnostico laboratorial.
description SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus) is the etiological agent responsible for the development of coronavirus disease (COVID-19). Which is a disease that affects the airways, and most often can cause pneumonia. Despite the viral origin, antimicrobial drugs are often prescribed, so that about 15% of patients with SARS-CoV-2 have a secondary infection caused by bacteria, which explains the antibiotic treatment. These drugs, when prescribed regardless of the existence of a bacterial infection, can lead to possible bacterial resistance. The objective of this work is to analyze the profile of laboratory tests of patients admitted to an ICU with severe forms of COVID-19, in a private hospital in a city in the southwestern region of Bahia. This is a documental study, with primary data source. The approach is quantitative, descriptive, exploratory, and cross-sectional, through data survey. Among the 52 medical records evaluated, it was possible to observe that the male gender had a higher rate of hospitalization and most of them were elderly. It is possible to observe an increase in the number of leukocytes and platelets after antibiotic therapy. And in relation to CRP, the value was significantly reduced after the administration of antimicrobial drugs. According to the analysis of the laboratory results, it was possible to observe that there were important alterations in the infection markers, which may be related to the use of antimicrobial drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-07
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/38199
10.33448/rsd-v11i16.38199
url https://rsdjournal.org/index.php/rsd/article/view/38199
identifier_str_mv 10.33448/rsd-v11i16.38199
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/38199/31622
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 16; e253111638199
Research, Society and Development; Vol. 11 Núm. 16; e253111638199
Research, Society and Development; v. 11 n. 16; e253111638199
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052730852769792